 |
9 Diseases |  |
0 Trials |
|
0 Trials |  |
3 News |  |
- | cerlapirdine (PF-5212365) / Pfizer
Trial termination: Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease (clinicaltrials.gov) - Aug 9, 2011
P2, N=526, Terminated, Sponsor: Pfizer
Active, not recruiting --> Terminated; See termination reason in detailed description.